Antagonistes de recepteur de fibrinogene

Fibrinogen receptor antagonists

Abstract

Antagonistes de récepteur de fibrinogène représentés par la formule (I) lesquels sont utilisés pour inhiber la fixation du fibrinogène sur les plaquettes du sang et pour inhiber l'agrégation de ces dernières.
Fibrinogen receptor antagonists of formula (I) are disclosed for use in inhibiting the binding of fibrinogen to blood platelets and for inhibiting the aggregation of blood platelets.

Claims

Description

Topics

Download Full PDF Version (Non-Commercial Use)

Patent Citations (3)

    Publication numberPublication dateAssigneeTitle
    EP-0352249-A1January 24, 1990Monsanto CompanyInhibiteurs de l'agrégation de plaquettes
    EP-0384362-A2August 29, 1990F. Hoffmann-La Roche AgGlycinderivatives
    US-4064255-ADecember 20, 1977Mar-Pha Societe D'etudes Et D'exploitation De MarquesCompositions containing new indole derivatives and their use in pharmacology

NO-Patent Citations (0)

    Title

Cited By (11)

    Publication numberPublication dateAssigneeTitle
    EP-3026432-A2June 01, 2016Brown UniversityVerfahren zur vorhersage der patientenreaktion auf eine behandlung mit biglycan
    US-5648368-AJuly 15, 1997Merck & Co., Inc.Fibrinogen receptor antagonists
    US-5672585-ASeptember 30, 1997La Jolla Cancer Research FoundationMethod and composition for treating thrombosis
    US-5780303-AJuly 14, 1998La Jolla Cancer Research FoundationMethod and composition for treating thrombosis
    US-6017877-AJanuary 25, 2000La Jolla Cancer Research FoundationMethod and composition for treating thrombosis
    US-6187757-B1February 13, 2001Ariad Pharmaceuticals, Inc.Regulation of biological events using novel compounds
    US-6521594-B1February 18, 2003La Jolla Cancer Research FoundationMethod and composition for treating thrombosis
    US-6649595-B2November 18, 2003Ariad Gene Therapeutics, Inc.Regulation of biological events using novel compounds
    US-6984635-B1January 10, 2006Board Of Trustees Of The Leland Stanford Jr. University, President And Fellows Of Harvard CollegeDimerizing agents, their production and use
    US-7067526-B1June 27, 2006Ariad Gene Therapeutics, Inc.28-epirapalogs
    US-7196192-B2March 27, 2007Ariad Gene Therapeutics, Inc.28-epirapalogs